Poves Elvira, Carballo Fernando, Ceballos Daniel, Alberca de Las Parras Fernando
Aparato Digestivo, Hospital Universitario Príncipe de Asturias, España.
Aparato Digestivo, Hospital Clínico Universitario Virgen de la Arrixaca, España.
Rev Esp Enferm Dig. 2023 Nov;115(11):636-643. doi: 10.17235/reed.2023.9860/2023.
the COVID-19 pandemic had a strong impact on the healthcare model. The Sociedad Española de Patología Digestiva (SEPD) offered gastroenterology care units (UAAD) an instrument (EFIC_AD) to record and analyze their efficacy and efficiency. Thus, the impact of the pandemic on the activity of UAAD was assessed.
A descriptive study, based on the EFIC_AD registry for the period 2019-2021, of activity regarding admissions, clinic visits, and endoscopic as well as non-endoscopic tests, and endoscopy room performance.
data were collected from up to 42 hospitals (22 with ≥ 500 beds). Overall, activity during 2020 compared to 2019 decreased by 12.30 % for admissions and 40 % for pH-metries (16.70 % for new clinic visits; 14.34 % for referrals from primary care; 24.70 % for gastroscopies; 32.50 % for colonoscopies; 31.00 % for endoscopic ultrasounds; 18.20 % for endoscopic retrograde cholangiopancreatography (ERCPs); 38.00 % for manometries; 23.60 % for abdominal ultrasounds; 36.17 % for liver transient elastographies [Fibroscan®]). The levels achieved during 2019 were not fully recovered during 2021 except for digestive motility studies, and virtually for endoscopy room performance rate (88.15 % in 2019; 67.77 % in 2020; 85.93 % in 2021).
during 2020 the COVID-19 pandemic led to a markedly decreased in specific activities at UAAD, which was not fully recovered in 2021 despite endoscopy room performance return to normal.
新冠疫情对医疗模式产生了重大影响。西班牙消化病学会(SEPD)为胃肠病护理单元(UAAD)提供了一种工具(EFIC_AD),用于记录和分析其疗效和效率。因此,评估了疫情对UAAD活动的影响。
基于2019 - 2021年期间EFIC_AD登记处的数据进行描述性研究,内容包括入院、门诊就诊、内镜及非内镜检查的活动情况以及内镜室表现。
收集了多达42家医院(22家床位≥500张)的数据。总体而言,与2019年相比,2020年的活动量下降情况如下:入院减少12.30%,pH值测量减少40%(新门诊就诊减少16.70%;初级保健转诊减少14.34%;胃镜检查减少24.70%;结肠镜检查减少32.50%;超声内镜检查减少31.00%;内镜逆行胰胆管造影术(ERCP)减少18.20%;测压减少38.00%;腹部超声检查减少23.60%;肝脏瞬时弹性成像[Fibroscan®]减少36.17%)。除消化动力研究外,2021年未完全恢复到2019年的水平,内镜室使用率实际上也未完全恢复(2019年为88.15%;2020年为67.77%;2021年为85.93%)。
2020年新冠疫情导致UAAD的特定活动显著减少,尽管内镜室使用率恢复正常,但2021年仍未完全恢复。